Second death linked to potential antibody treatment for Alzheimer's disease

By Science
| November 30, 2022

Woman's brain hemorrhage while receiving Eisai's widely heralded lecanemab heightens concerns overs its safety.

Full story

#1

Recent research on Paxlovid shows there is "solid data on its effectiveness," a co-author of the study told HealthLeaders. ...

A new personal protective equipment manufacturing company is set to open in Cincinnati next year. ...